-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, N777Oel4lMhky1tx0GU5TfoTRHdY76SS84jhoBiSFLApPoCFR6oHVrYswKhHMgKZ 1A21LjAbi4U0IhiCziZusA== 0001127602-10-013955.txt : 20100512 0001127602-10-013955.hdr.sgml : 20100512 20100512193209 ACCESSION NUMBER: 0001127602-10-013955 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100511 FILED AS OF DATE: 20100512 DATE AS OF CHANGE: 20100512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Diradoorian Raymond H CENTRAL INDEX KEY: 0001352121 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10269 FILM NUMBER: 10825881 MAIL ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN INC CENTRAL INDEX KEY: 0000850693 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 951622442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142464500 MAIL ADDRESS: STREET 1: P.O. BOX 19534 CITY: IRVINE STATE: CA ZIP: 92713-9534 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2010-05-11 0000850693 ALLERGAN INC AGN 0001352121 Diradoorian Raymond H 2525 DUPONT DRIVE IRVINE CA 92612 1 EVPGlobal Technical Operations Common Stock 2010-05-11 4 M 0 13494 40.0887 A 15952 D Common Stock 2010-05-11 4 S 0 13494 62.4811 D 2458 D Common Stock 6676.4515 I By 401(k) Common Stock 3537.5846 I By Esop Employee Stock Option (Right to Buy) 40.0887 2010-05-11 4 M 0 13494 0 D 2011-02-01 Common Stock 13494 0 D The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $62.3973 to $62.5800, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote. Shares allocated to reporting person's SIP account as of reporting date. Shares allocated to the reporting person's ESOP account as of reporting date. The option became exercisable in four equal annual installments beginning February 2, 2002. /s/ Matthew J. Maletta, attorney-in-fact for Raymond H. Diradoorian 2010-05-12 -----END PRIVACY-ENHANCED MESSAGE-----